Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist.
暂无分享,去创建一个
J. Reynolds | D. Chapelle | R. Goldbach-Mansky | M. Garg | A. Reed | G. M. Sanchez | P. Dancey | A. D. de Jesus | R. Herzog | R. Rivas-Chacón | T. W. Muskardin | R. Rivas-Chacon | G. Sanchez